• GPhC registered UK pharmacy
  • Free clinical support
  • Discreet delivery
Patient Education Guide · Happy Pharmacy

Wegovy Pill Long Term Effects: Evidence and Weight Maintenance

Wegovy pill long term effects include potential ongoing weight management benefits and the need to monitor side effects and treatment response. The Wegovy pill has direct trial evidence over 64 weeks; longer injection studies provide useful context but do not prove identical long-term tablet outcomes. This guide explains the evidence, regular reviews and planning for stopping or continuing treatment.
13.6% weight lossAverage with the 25mg daily tablet at 64 weeks in OASIS 4, including treatment discontinuations.
15.2% at 2 yearsAverage weight loss with the weekly 2.4mg injection in STEP 5 — not a tablet study.
Around ⅔ regainedOf previous weight loss, one year after stopping the injection and lifestyle support in the STEP 1 extension.

Content last updated: 1 October 2026

Treatment Duration

1. How Long Should You Take the Wegovy Pill?

Treatment duration is an individual decision based on benefit, tolerability, health needs and your preferences. Reaching a weight goal does not automatically mean that treatment should stop, and continued prescribing still needs review.

The tablet is used for weight loss and weight maintenance alongside diet and physical activity. Discuss practical issues such as cost or difficulty taking it rather than changing the dose or stopping and restarting without advice.

StartingBuild up carefullyFollow the prescribed dose schedule and report symptoms.
OngoingReview responseAssess weight trend, tolerability and the daily routine.
MaintenanceRevisit goalsWeight maintenance may be a treatment benefit.
Any changeMake a planAgree changes, stopping or restarting with your prescriber.

See the Wegovy pill dosage guide for the usual tablet dose stages. These stages are not a guaranteed timeline for weight loss.

Clinical Evidence

2. What Do We Know About Wegovy Pill Long Term Effects?

The strongest evidence directly relevant to the 25mg tablet comes from OASIS 4. Studies of injectable semaglutide help explain longer-term maintenance and stopping, but must be identified as injection evidence.

Study and formulationWhat it foundWhat it cannot tell us
OASIS 4 — daily 25mg tabletAt 64 weeks, average weight change was −13.6%, compared with −2.2% with placebo, in the analysis including treatment discontinuations.It does not establish tablet outcomes over several years or predict an individual result.
STEP 5 — weekly 2.4mg injectionAverage weight loss was 15.2% at 104 weeks. The average weight curve plateaued around week 60 and was maintained thereafter.These are injection results, not a two-year tablet trial.
STEP 1 extension — stopping the injectionParticipants regained about two-thirds of their previous weight loss over the year after semaglutide and the structured lifestyle intervention stopped.This exploratory follow-up does not predict exactly how much someone stopping tablets will regain.

The two-thirds figure comes from the STEP 1 extension, not STEP 4. It describes a group average under those study conditions, not an inevitable outcome or a measure of someone’s effort.

Our Wegovy pill results guide explains the tablet trial figures in more detail.

Evidence limits matterThe same active ingredient does not make every formulation, dose, study population or follow-up period interchangeable. Long-term tablet benefits and uncommon risks need continued monitoring.
Long-Term Treatment

3. Monitoring Benefits and Side Effects

Long-term treatment should remain an active review process. Agree follow-up timing with your prescriber, and ask for an earlier review if symptoms, medicines or circumstances change.

Review areaWhat to discuss
Weight and health goalsWhether treatment is providing a useful benefit, including maintenance.
Side effects and nutritionPersistent digestive symptoms, difficulty eating or drinking, and any new concerns.
Other medicinesNew prescriptions, supplements or changes that may affect treatment or monitoring.
Medical conditionsAny change in health, including diabetes management and relevant blood tests.
Daily tablet routineWhether fasting, water and waiting instructions are practical and followed.
Pregnancy plans or proceduresTell your prescriber about pregnancy plans and upcoming anaesthesia or sedation.

Read about Wegovy pills side effects for common symptoms and warning signs. New or persistent symptoms should not be dismissed simply because you have taken treatment for a long time.

Does a weight plateau mean the pill has stopped working?

A stable weight can represent maintenance rather than treatment failure. Review your weight trend, routine and goals with your prescriber. There is no reliable rule that a plateau will resolve within four to eight weeks, and it is not a reason to increase the dose yourself.

Our guide to how to take the Wegovy pill explains the daily administration requirements.

Symptoms needing prompt help

Stop taking Wegovy and seek urgent medical help for severe, persistent abdominal pain, which may spread to your back. Sudden loss of vision or rapidly worsening eyesight needs urgent assessment. Seek advice if vomiting or diarrhoea makes it hard to stay hydrated.

Stopping Treatment

4. Discussing Whether to Continue or Stop

Your preferences and practical circumstances are part of the decision. Discuss the benefits you are experiencing alongside side effects, cost, daily routine and future health plans.

Reasons to discuss continuing

  • Treatment is helping you meet agreed goals.
  • The routine is manageable and side effects are acceptable.
  • Maintaining weight loss remains an important health goal.

Reasons to request a review

  • Persistent symptoms or difficulty eating and drinking.
  • Cost, supply or routine problems.
  • Pregnancy plans, a change in health or a wish to stop.

Is there a standard tapering schedule?

The tablet prescribing information does not provide a standard dose-reduction schedule for stopping, and there is no established tablet taper that guarantees prevention of weight regain. Do not follow an online step-down schedule or alter your prescription yourself. Agree what to do with your prescriber.

Pregnancy and urgent symptoms need specific advice

Wegovy must not be used during pregnancy and should be stopped at least two months before a planned pregnancy. Contact your prescriber if pregnancy occurs. Do not delay urgent medical help for a serious suspected side effect while waiting for a routine stopping plan.

Lifestyle Foundations

5. Supporting Weight Maintenance

Food, activity, sleep and support can help you look after your health during and after treatment. They do not guarantee that weight regain will be prevented, and needing continued support is not a personal failure.

🥗

Food

Choose a sustainable eating pattern that provides enough nutrients.
🏃

Movement

Build activity and strength work around your ability.
😴

Sleep

Work towards a regular sleep routine that fits your life.
🧠

Support

Ask for help with hunger, wellbeing and changes in eating.
Eating habitPractical approach
Balanced mealsInclude a variety of vegetables, fruit, protein foods and higher-fibre carbohydrates.
Adequate nutritionAsk for tailored advice if reduced appetite makes it hard to eat enough.
Sustainable routineChoose meal patterns you can maintain; avoid extreme restriction.
Personal needsA dietitian can tailor advice to medical conditions, preferences and activity.

For adults able to follow the general NHS activity guidance, aim towards at least 150 minutes of moderate activity or 75 minutes of vigorous activity a week, plus strength activities on at least two days. Start gradually and adapt this to your health and ability.

ActivityUseful approach
Walking, cycling or swimmingChoose activities you enjoy and build up gradually.
Strength activitiesWork the major muscle groups with suitable weights, bands or bodyweight exercises.
Everyday movementBreak up long periods of sitting when you can; there is no compulsory step target for everyone.
After Stopping

6. Planning Follow-Up After the Wegovy Pill

Appetite and weight can change after stopping. There is no fixed week-by-week pattern that applies to everyone, so agree a follow-up plan rather than relying on a predicted timetable.

Part of the planWhat to agree
Before stoppingYour reason for stopping, any urgent concerns and how other conditions will be managed.
MonitoringA manageable way to follow weight, appetite, symptoms and wellbeing.
SupportWho to contact about nutrition, activity or difficulties with eating.
When to reviewA planned appointment and reasons to ask for earlier help.
If weight increasesDiscuss the trend and options without blame; do not restart an old prescription yourself.
Restarting needs a fresh assessment. Suitability and the dose depend on your circumstances and the length of the treatment break. A previous prescription does not establish the right restart dose.

Review who can take the Wegovy pill and tell your prescriber about any changes in your health or medicines.

The Bigger Picture

7. Making an Ongoing Treatment Plan

Weight management may need continuing support, whether or not medicine remains part of your plan. Review the benefits and burdens of treatment together rather than assuming everyone should continue indefinitely or stop at a particular weight.

If cost is affecting your decision, check current Wegovy pill prices and discuss the available options before arranging a change.

This guide provides general information. Your prescriber should help you decide whether to continue, change or stop treatment based on your individual circumstances.
Your Questions Answered

Wegovy Pill Long Term Effects: FAQs

Potential effects include continued weight management benefits alongside ongoing risks of side effects. The direct 25mg tablet trial followed treatment for 64 weeks. Longer injection studies are useful context, but they do not establish identical tablet outcomes over several years.
The appropriate duration depends on your response, tolerability, health needs and preferences. Agree regular reviews with your prescriber rather than treating the prescription as an automatic lifelong commitment.
Weight regain is possible. The often-quoted two-thirds figure comes from the STEP 1 injection extension, where both medicine and structured lifestyle intervention stopped. It is not a tablet-specific forecast for you.
Not necessarily. Maintaining a lower weight can be a benefit. Review the overall trend, daily routine and goals with your prescriber; do not increase your dose to try to overcome a plateau.
There is no standard tablet taper in the prescribing information that is proven to prevent regain. Ask your prescriber for an individual plan rather than using a self-directed dose-reduction schedule.
Ask your prescriber for a new assessment and dose instructions. Do not restart at your previous dose without advice, particularly after a longer break or a change in health.
Agree a sustainable eating and activity plan, look after sleep and wellbeing, and arrange follow-up. Supportive habits are valuable, but they do not guarantee prevention of weight regain.

Review Your Wegovy Pill Options

Check current treatment information and prices, and discuss ongoing treatment with your prescriber. Supply depends on an assessment of suitability.

View Wegovy pill treatment and prices
Sources: UK tablet prescribing information, including OASIS 4 | UK patient leaflet | STEP 5 injection trial | STEP 1 injection extension | NHS physical activity guidance. Content updated: 1 October 2026. General information, not a substitute for personalised medical advice.